An Evaluation of a Training Program in Restraint-Free Care for Individuals with Dementia Christina Garrison-Diehn, Clair Rummel, & Jane E.

Size: px
Start display at page:

Download "An Evaluation of a Training Program in Restraint-Free Care for Individuals with Dementia Christina Garrison-Diehn, Clair Rummel, & Jane E."

Transcription

1 An Evaluation of a Training Program in Restraint-Free Care for Individuals with Dementia Christina Garrison-Diehn, Clair Rummel, & Jane E. Fisher

2 Background Disease. (Xu, Kochanek & Tejada-Vera, 2009) Dementia is the leading cause of nursing home admission (Eaker, Vierkant, & Mickel, 2002). 70% of individuals with dementia are living in a nursing home at the end of their life (Mitchell, Kiely & Hamel, 2005) Top reasons for nursing home placement: (Buhr, Kuchibhatla & Clipp, 2006) Need for more skilled care Dementia related behaviors

3 Background Behavioral challenges: Agitation Aggression Delusional speech Hallucinations Repetitive vocalizations Wandering Depressed affect Social withdrawal Prevalence rates = over 60% (Lyketsos, et al. 2002).

4 Traditional Model of Dementia Behavioral challenges = symptoms of neuropathology Attribution of behavioral disturbances as a symptoms of dementia increases the risk of excess disability Impairment in function beyond that which can be accounted for by the disease. (Dawson, Wells & Kline, 1993) Frequency of adaptive behavior is diminished prematurely. (Fisher et al.,2007) First line of treatment: antipsychotic medications

5 Antipsychotics Most common treatment = antipsychotic medications Prescribed off-label 32-58% of nursing home residents are prescribed antipsychotics (Ronchon et al., 2007; Margallo-Lana et al., 2001; Kamble et al., 2009) Typical: haloperidol, thorazine Atypical: risperidone, olanzapine Moderate evidence of efficacy (Agency of Healthcare Research and Quality, 2007)

6 Antipsychotics Adverse effects offset the advantages (Ballard et al., 2009; Schneider et al., 2006; Ballard & Waite, 2006). Increased risk of: Mortality Cerebrovascular adverse events Extrapyramidal symptoms Upper respiratory infections Sedation & confusion Premature reduction of adaptive functioning Decreased quality of life (Ballard & Margallo-Lana, 2004)

7 Contextual Model of Dementia Behavioral challenges = inability to report private events & have needs met (Fisher et al., 2007) Behavior communicates what words cannot Intervention = medical assessment + environmental assessment Evidence for contextual model: modification of the social and physical environment results in a reduction of these problems and a reduction in excess disability (Yury & Fisher, 2007; Burgio & Stevens, 1999; Buchanan & Fisher, 2002; Cohen-Mansfield & Werner, 1998).

8 Restraint Free Care Training Program Development Quality and Compliance Goals: 1. Increase staff knowledge of evidence-based practices for dementia care. 2. Reduce the use of psychotropic medications to manage behavioral challenges in residents with dementia. 3. Increase facilities ability to keep challenging residents. 4. Improve quality of life for residents with dementia by reducing excess disability and preserving adaptive functioning.

9 Restraint Free Care Training Program Development Program characteristics Available to long-term care facilities on a voluntary basis No cost to the facility Needs assessment conducted pre-training Train-the-trainer model 10 hours of training Consultation services post-training Aid in providing trainings to full staff Behavioral consultation for challenging cases Satisfied state requirement for dementia training

10 Restraint Free Care Training Program Overview Topics Covered: Stress of Dementia Care Communication Techniques Excess Disability Assessing Pain Delirium Depression Promoting Choice Delusions and Hallucinations Sexuality Behavioral Interventions Structured trainings designed to include idiographic examples from each specific facility throughout the trainings

11 Program Timeline Development & Recruitment Trainings Conducted January 2010 April 2010 May 2010 November 2010 Data Collection Through April 2011

12 Facility Characteristics Facility Type Skilled Nursing Group Home N Residents on Antipsychotic Medication Pre Training Residents on Antianxiety medication Pre Training 8 <10% - 60% 10% - 50% 12 <10% - 100% <10% - 80%

13 Participant Demographics N = 64 Gender: 85% Female Education: High School: 5% 9% 30% Asian African American Hispanic Some College: 17% AA: 17% BA: 38% Masters/Professional: 15% 47% 5% 3% 6% Native Islander Caucasian Unreported

14 Outcome Measures: Trainers Pre & Post- Training Measures - Modified (ADKS; Carpenter et al., 2009) Approaches to Dementia Questionnaire (ADQ; Lintern et al., 2000 ) Vignette 79-year-old woman Facility resident: 2 years. Recently Mrs. Hansen has been less talkative to her fellow residents and less more frequently and she is refusing to let staff give her a shower.

15 Outcome Measures Observational Data Collection Two skilled-nursing facilities in Reno, NV Resident criteria Dementia diagnosis Staff report of challenging behaviors Systematic observation of residents Staff behavior and affect when interacting with observed residents Pre- and post-training & post-facility wide training Chart review PRN administration, behavioral incidents, assessments, consults, illness, hospitalizations Medication Administration Records, nursing notes, behavioral reports, incident reports

16 Outcome Measures 3- Month Follow Up Facility characteristics Antipsychotic medication use Staff turnover Evaluation and feedback form Rate specific training objectives Room for comments Status of facility wide trainings

17 Pre & Post Results Measure N Pre Post P-value ADKS * ADKS - Contextual * ADQ Vignette Vignette - Communication Strategies * Vignette Assessment * Vignette - Consultation Vignette Environmental Strategies

18 Data Analysis underway Resident behavior + Chart review (staff behavior) Systematic review of impact of training on staff behavior Examining observed changes in adaptive behavior and Versus staff charted behavior Pain assessment Medical assessment Medication administration

19 Aggregate Observational Data of Staff Facility I IRR trials = 15% Trials Positive Staff Behavior Negative Staff Behavior Positive Affect Negative Affect Neutral Affect Pre 38 84% 12% 87% 5% 16% Post 63 86% 6% 68% 1% 7% 3 month follow-up 48 72% 13% 48% 10% 69% Facility II IRR trials = 45% Trials Positive Staff Behavior Negative Staff Behavior Positive Affect Negative Affect Neutral Affect Pre 84 81% 4% 50% 4% 74% Post % 16% 49% 3% 49% 3 month follow-up 83 87% 11% 43% 4% 69%

20 Agreement Facility I Mean Range % agreement Facility II Mean Range % agreement

21 Modules given to full staff Status of Trainings at 3 month follow-up (9 forms received) Managing the stress of dementia care 5 Knowing the facts about dementia 5 Communicating the facts about dementia 5 Knowing about excess disability 5 Assessing pain 4 Promoting choice 4 Making sense of delusions and hallucinations 3 Sexuality in long-term care 3 Ruling out excess disability 3 Ruling out delirium and depression 3 The contextual ABCs of dementia care 2 Searching for clues Part 1: Antecedent interventions 3 Searching for clues Part 2: Consequent Interventions 2

22 3-Month Follow-up Feedback (9 respondents) Criteria Articulation of training program objectives Meeting of training program objectives Effectiveness of teaching methods Flow and style of presentation Relevance of information to your situation Usefulness of handouts &/or training material Usefulness of examples Excellent Ratings Very Good Ratings Good Ratings Average Ratings Poor Ratings

23 3-Month Follow-up Feedback Reported psychotropic medication use No significant changes Anti-psychotic Anti-anxiety Responders comments Helpfulness of the training program Suggested improvements Trainings impact on staff ability to manage challenging behaviors manage challenging behaviors

24 Discussion Observational data does not indicate that the training program had an impact on staff interactions with residents Chart review data will indicate if there was an impact on other staff behavior Staff reported enjoying content and delivery of the training Especially the use of in-facility examples

25 Discussion Model based on identifying idiosyncratic barriers to effective caregiving and guided practice More intense intervention may be needed Limited use of follow-up consultation Buy-in from administration

26 Contact:

27 References Agency of Healthcare Research and Quality (2007). Efficacy and comparative effectiveness of off-label use of atypical anti-psychotics [publication no. 07-EHC003-EF]. Rockville (MD): Agency of Healthcare Research and Quality. Ballard C. & Waite J. (2006). The effectiveness of atypical antipsychotics for the treatment of aggression Ballard, C., Hanney, M.L., Douglas, S., McShane, R., Kossakowski, K., et al. (2009). The dementia antipsychotic withdrawal trial (DART-AD): Long-term follow-up of a randomized placebo-controlled trial. The Lancet Neurology, 8, Ballard, C.G. & Margallo-Lana, M.L. (2004). The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities. Journal of Clinical Psychiatry, 65(11), Buchanan, J.A., & Fisher, J.E. (2002). Functional assessment and noncontingent reinforcement in the treatment of disruptive vocalization in elderly dementia patients. Journal of Applied Behavior Analysis, 35, for improving discussions with families prior to the transition. The Gerontologist, 46, Burgio, L.D., & Stevens, A.B. (1999). Behavioral interventions and motivational systems in the nursing home. In R. Schulz, G. Maddox, & M.P. Lawton (Eds.), Annual review of gerontology and geriatrics: Vol. 18. Focus on interventions research with older adults (pp ). New York: Springer Cohen-Mansfield J, & Werner, P. (1998). The effects of an enhanced environment on nursing home residents who pace. Gerontologist 38(2), Dawson, P., Wells, D.L., & Kline, K. (1993). related dementias. New York: Springer.

28 References Eaker, E.D., Vierkant, R.A., & Mickel S.F. (2002). Predictors of nursing home admission and/or death in -based study. Journal of Clinical Epidemiology, 55: Lyketsos, C. G.,Lopez, O., Jones, B., Fitzpatrick, A.L., Breitner, J., Dekosy, S. (2002). Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: Results from the cardiovascular health study. Journal of the American Medical Association, 288, Margallo- pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments. International Journal of Geriatric Psychiatry, 16, Mitchell, S.L., Kiely, D.K., Hamel, M.B. (2004). Dying with advanced dementia in the nursing home. Archives of Internal Medicine, 164, Ronchon, P.A., Stukel, T.A., Bronskill, S.E., Gomes, T., Sykora, K. et al. (2008). Variation in nursing home antipsychotic prescribing rates. Archives of Internal Medicine, 167(7), Schneider, L.S., Tariot, P.N., Dagerman, K.S., Davis, S.M., Hsiao, J.K., et al. (2006). Effectiveness of The New England Journal of Medicine, 355, Xu, J., Kochanek, K.D. & Tejada-Vera, B. (2009). Deaths: Preliminary Data for National Vital Statistics Reports 58(1). Hyattsville, Md.: National Center for Health Statistics. Yury, C., & Fisher, J.E. (2007). Meta-analysis of the effectiveness of atypical antipsychotics for the treatment of behavioral problems in persons with dementia. Psychotherapy and Psychosomatics, 76,

Management of the Acutely Agitated Long Term Care Patient

Management of the Acutely Agitated Long Term Care Patient Management of the Acutely Agitated Long Term Care Patient 80 60 Graying of the Population US Population Over Age 65 Millions of Persons 40 20 0 1900 1920 1940 1960 1980 1990 2010 2030 Year Defining Dementia

More information

Describe the University of Nevada, Reno Nevada

Describe the University of Nevada, Reno Nevada Preventing Excess Disability and Promoting Quality of Life University of Nevada, Reno Overview Describe the Nevada Caregiver Support Center contextual model of dementia care Describe the concept of excess

More information

Where PASRR and Dementia Meet

Where PASRR and Dementia Meet Where PASRR and Dementia Meet Department of Psychology University of Nevada, Reno Overview What are the challenges in detecting and effectively responding to dementia & psychiatric related symptoms in

More information

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD

Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias. Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, MD Psychiatric and Behavioral Symptoms in Alzheimer s and Other Dementias Aaron H. Kaufman, M.D. Health Sciences

More information

Antipsychotic Medications

Antipsychotic Medications TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood

More information

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia

More information

The place for treatments of associated neuropsychiatric and other symptoms

The place for treatments of associated neuropsychiatric and other symptoms The place for treatments of associated neuropsychiatric and other symptoms Luca Pani dg@aifa.gov.it London, 25 th November 2014 Workshop on Alzheimer s Disease European Medicines Agency London, UK Public

More information

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA

Disclosure. Speaker Bureaus. Grant Support. Pfizer Forest Norvartis. Pan American Health Organization/WHO NIA HRSA Disclosure Speaker Bureaus Pfizer Forest Norvartis Grant Support Pan American Health Organization/WHO NIA HRSA How Common is Psychosis in Alzheimer s Disease? Review of 55 studies 41% of those with Alzheimer

More information

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit

Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Organization: Sheppard Pratt Health System Solution Title: Lean Methodology: Appropriate Antipsychotic Use on an Inpatient Dementia Unit Problem: For dementia patients, antipsychotic medications are prescribed

More information

How I Treat Aggression in Outpatients With Dementia. C. Omelan MD, FRCP(C)

How I Treat Aggression in Outpatients With Dementia. C. Omelan MD, FRCP(C) How I Treat Aggression in Outpatients With Dementia C. Omelan MD, FRCP(C) Conflict of Interest I have no potential conflicts of interest to declare Overview Outline the prevalence of aggression Review

More information

Psychosis and Agitation in Dementia

Psychosis and Agitation in Dementia Psychosis and Agitation in Dementia Dilip V. Jeste, MD Estelle & Edgar Levi Chair in Aging, Director, Stein Institute for Research on Aging, Distinguished Professor of Psychiatry & Neurosciences, University

More information

NKR 55 demens og medicin PICO 2 seponering af antipsykotisk medicin versus forsat behandling Review information

NKR 55 demens og medicin PICO 2 seponering af antipsykotisk medicin versus forsat behandling Review information NKR 55 demens og medicin PICO 2 seponering af antipsykotisk medicin versus forsat behandling Review information Authors Sundhedsstyrelsen 1 1 [Empty affiliation] Citation example: S. NKR 55 demens og medicin

More information

Behavioral and Psychological Symptoms of dementia (BPSD)

Behavioral and Psychological Symptoms of dementia (BPSD) Behavioral and Psychological Symptoms of dementia (BPSD) Chris Collins - Old Age Psychiatrist, Christchurch chris.collins@cdhb.health.nz Approaching BPSD: the right mindset Assessment Non-drug management

More information

The burden of psychotropic drug prescribing in people with dementia: a population database study

The burden of psychotropic drug prescribing in people with dementia: a population database study Age and Ageing 2010; 39: 637 642 doi: 10.1093/ageing/afq090 Published electronically 12 July 2010 The Author 2010. Published by Oxford University Press on behalf of the British Geriatrics Society. All

More information

Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches

Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches Optimal Management of Challenging Behaviours in Dementia: An Update on Pharmacologic and Non-Pharmacologic Approaches Andrea Iaboni, MD, DPhil, FRCPC Toronto Rehab Institute, UHN Learning objectives Recognize

More information

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.

More information

NeuroPharmac Journal ISSN: Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M.

NeuroPharmac Journal ISSN: Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M. ISSNISSN ISSN: 2456-3927 NeuroPharmac Journal Alzheimer s Disease: Pharmacotherapy of noncognitive symptoms Aslam Pathan; Abdulrahman M. Alshahrani www. neuropharmac.com Jan-April 2018, Volume 3, Issue

More information

Management of Agitation in Dementia. Kimberly Triplett Ferguson, MS4

Management of Agitation in Dementia. Kimberly Triplett Ferguson, MS4 Management of Agitation in Dementia Kimberly Triplett Ferguson, MS4 Objectives 1. Review recommended evaluation of agitated patients with dementia. 2. Discuss evidence concerning nonpharmacologic management.

More information

Behavior Problems: in Long Term Care and Assisted Living

Behavior Problems: in Long Term Care and Assisted Living Behavior Problems: Dementia and Mental Illness in Long Term Care and Assisted Living Module I Dr. David A. Smith, M.D., FAAFP, CMD mmlearn.org is a program of Morningside Ministries Cell Phones and Pagers

More information

Management of Behavioral Problems in Dementia

Management of Behavioral Problems in Dementia Management of Behavioral Problems in Dementia Ghulam M. Surti, MD Clinical Assistant Professor Department of Psychiatry and Human Behavior Warren Alpert Medical School of Brown University Definition of

More information

Best Practice Guideline for Accommodating and Managing Behavioural and Psychological Symptoms of Dementia in Residential Care

Best Practice Guideline for Accommodating and Managing Behavioural and Psychological Symptoms of Dementia in Residential Care Best Practice Guideline for Accommodating and Managing Behavioural and Psychological Symptoms of Dementia in Residential Care A Person-Centered Interdisciplinary Approach October 25, 2012 Acknowledgements

More information

ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good?

ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good? ANTIPSYCHOTICS IN LONG TERM CARE: Are We Doing More Harm than Good? STEPHANIE M. OZALAS, PHARMD, BCPS, BCGP VA MARYLAND HEALTH CARE SYSTEM BALTIMORE, MD DISCLOSURES Off-label use of medications will be

More information

Re: Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities

Re: Medicare and Medicaid Programs; Reform of Requirements for Long-Term Care Facilities Public Policy Division 202.393.7737 p 1212 New York Ave NW 866.865.0270 f Suite 800 www.alz.org Washington, DC 20005 Andy Slavitt Acting Administrator Centers for Medicare & Medicaid Services Department

More information

Delirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care

Delirium. A Plan to Reduce Use of Restraints. David Wensel DO, FAAHPM Medical Director Midland Care Delirium A Plan to Reduce Use of Restraints David Wensel DO, FAAHPM Medical Director Midland Care Objectives Define delirium Describe pathophysiology of delirium Understand most common etiologies Define

More information

Behavioural and Psychological Symptoms and Medications Presentation

Behavioural and Psychological Symptoms and Medications Presentation 1 2 Vover s research indicated that antipsychotic med are frequently used for individual presenting with disruptive behaviours. This often combined with physical restraints Efficacy of use not justify

More information

Vanderbilt & Qsource Webinar Series

Vanderbilt & Qsource Webinar Series Vanderbilt & Qsource Webinar Series Vanderbilt Medical Center Vanderbilt University Center for Quality Aging Qsource Session #1: Introduction to Dementia Care & QAPI Session #2: Dementia & Behavioral Disturbances

More information

Antipsychotics for Dementia Under Control or Over-Prescribed?

Antipsychotics for Dementia Under Control or Over-Prescribed? Antipsychotics for Dementia Under Control or Over-Prescribed? Nathaniel Hedrick, PharmD ProCare HospiceCare, Manager of Clinical Services Learning Objectives Summarize the disease progression and most

More information

Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia

Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia Aine Leen, Kieran Walsh, David O Sullivan, Denis O Mahony, Stephen Byrne, Margaret Bermingham Pharmaceutical Care Research Group,

More information

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017 Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic

More information

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline

American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline American Board of Psychiatry and Neurology, Inc. Geriatric Psychiatry Core Competencies Outline I. Geriatric Psychiatry Patient Care and Procedural Skills Core Competencies A. Geriatric psychiatrists shall

More information

Silvia Duong, 1,2 Kam-Tong Yeung, 1 and Feng Chang 1,3. 1. Introduction

Silvia Duong, 1,2 Kam-Tong Yeung, 1 and Feng Chang 1,3. 1. Introduction Aging Research Volume 2015, Article ID 570410, 6 pages http://dx.doi.org/10.1155/2015/570410 Research Article Intramuscular Olanzapine in the Management of Behavioral and Psychological Symptoms in Hospitalized

More information

Integrating INTERACT into Interim Pharmacist Reviews

Integrating INTERACT into Interim Pharmacist Reviews Integrating INTERACT into Interim Pharmacist Reviews Chad R. Worz, Pharm.D. President, Medication Managers, LLC Adjunct Assistant Professor of Pharmacy Practice, University of Cincinnati, College of Pharmacy

More information

Reducing Antipsychotic Drug Use in Long Term Care

Reducing Antipsychotic Drug Use in Long Term Care Reducing Antipsychotic Drug Use in Long Term Care Janice S. Ceriotti, RPh, CGP Director of Clinical Services Omnicare Pharmacies / Eastern MO Goals and Objectives Understand the history of Antipsychotics

More information

The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature

The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature Review article: The efficacy of Rivastigmine in the management of the behavioral and psychological symptoms of lewy body dementia- a review of literature Dr. Ivan Netto 1, Aditya Iyer 2, Dr. Prathamesh

More information

Risks of Antipsychotics use In Dementia

Risks of Antipsychotics use In Dementia AHCA/NCAL Quality Initiative for Assisted Living Webinar Series: Safely Reducing the Off-Label Use of Antipsychotics Risks of Antipsychotics use In Dementia Sanjay P. Singh, MD Chairman & Professor, Department

More information

Delirium. Assessment and Management

Delirium. Assessment and Management Delirium Assessment and Management Goals and Objectives Participants will: 1. be able to recognize and diagnose the syndrome of delirium. 2. understand the causes of delirium. 3. become knowledgeable about

More information

Caregiver Mediated Intervention. Trumps Pharmacotherapy for BPSD

Caregiver Mediated Intervention. Trumps Pharmacotherapy for BPSD Caregiver Mediated Intervention DEMENTIA RESEARCH Trumps Pharmacotherapy for BPSD Henry Brodaty and Caroline Arasaratnam Dementia Collaborative Research Centre Assessment and Better Care Collaborative

More information

Recognition and Management of Behavioral Disturbances in Dementia

Recognition and Management of Behavioral Disturbances in Dementia Recognition and Management of Behavioral Disturbances in Dementia Danielle Hansen, DO, MS (Med Ed), MHSA INTRODUCTION 80% 90% of patients with dementia develop at least one behavioral disturbances or psychotic

More information

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia

Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Screening and Management of Behavioral and Psychiatric Symptoms Associated with Dementia Measure Description Percentage of patients with dementia for whom there was a documented screening* for behavioral

More information

Critical Care Pharmacological Management of Delirium

Critical Care Pharmacological Management of Delirium Critical Care Pharmacological Management of Delirium Policy Title: in the Critical Care Unit Executive Summary: This policy provides guidance Pharmacological Management of delirium in the Critical Care

More information

Antipsychotic use in dementia: a systematic review of benefits and risks from metaanalyses

Antipsychotic use in dementia: a systematic review of benefits and risks from metaanalyses 658463TAJ0010.1177/2040622316658463Therapeutic Advances in Chronic DiseaseRR Tampi, DJ Tampi research-article2016 Therapeutic Advances in Chronic Disease Original Research Antipsychotic use in dementia:

More information

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease

Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease Clinical Trial Designs for RCTs focussing on the Treatment of Agitation in people with Alzheimer s disease Professor Clive Ballard Dr Byron Creese University of Exeter, UK Guardian guide for 2018: Top

More information

Pharmacological Treatment of Aggression in the Elderly

Pharmacological Treatment of Aggression in the Elderly Pharmacological Treatment of Aggression in the Elderly Howard Fenn, MD Adjunct Clinical Associate Professor Department of Psychiatry and Behavioral Sciences Stanford University Self-Assessment Question

More information

GERIATRIC ADULT MENTAL HEALTH SPECIALTY TEAM TRAINING MODULES

GERIATRIC ADULT MENTAL HEALTH SPECIALTY TEAM TRAINING MODULES GERIATRIC ADULT MENTAL HEALTH SPECIALTY TEAM TRAINING MODULES Title of Presentation Length Description ACCEPTING THE CHALLENGE DVD created by Alzheimer s NC. ALTERNATIVES TO RESTRAINTS 1 hour Overview

More information

Evidence-Based Interventions to Improve Caregiver and Patient Outcomes in Dementia

Evidence-Based Interventions to Improve Caregiver and Patient Outcomes in Dementia Evidence-Based Interventions to Improve Caregiver and Patient Outcomes in Dementia Alan B. Stevens, PhD Professor, Department of Medicine Vernon D. Holleman-Lewis M. Rampy Centennial Chair in Gerontology

More information

Delirium. Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta

Delirium. Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta Delirium Geriatric Giants Lecture Series Divisions of Geriatric Medicine and Care of the Elderly University of Alberta Overview A. Delirium - the nature of the beast B. Significance of delirium C. An approach

More information

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017.

DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. DEMENTIA and BPSD in PARKINSON'S DISEASE. DR. T. JOHNSON. NOVEMBER 2017. Introduction. Parkinson's disease (PD) has been considered largely as a motor disorder. It has been increasingly recognized that

More information

THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL

THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL DID YOU KNOW THE BEHAVIOURAL VITAL SIGNS (BVS) TOOL. Did you know that it is essential to know the target cluster(s)/symptom(s) one is treating to guide and monitor non-pharmacological approaches and pharmacological

More information

PSYCHOTROPIC SOLUTIONS

PSYCHOTROPIC SOLUTIONS PSYCHOTROPIC SOLUTIONS A proactive approach to antipsychotic medication management A Quality Use of Medicines initiative by Choice Aged Care Copyright 2018 Key Senate Committee Recommendations: All RACF

More information

Cambridge University Press Effective Treatments in Psychiatry Peter Tyrer and Kenneth R. Silk Excerpt More information

Cambridge University Press Effective Treatments in Psychiatry Peter Tyrer and Kenneth R. Silk Excerpt More information Organic disorders 1 Delirium Based on Delirium by Laura Gage and David K. Conn in Effective Treatments in Psychiatry, Cambridge University Press, 2008 Introduction Delirium needs treatment for both its

More information

PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES

PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES PSYCHOTROPIC MEDICATIONS IN LTC CHALLENGES AND OPPORTUNITIES FOR BEST PRACTICES Coleen Kayden, RPh Medication Information Services Division of Williams Apothecary Conflicts of Interest None to report PANAC

More information

MORTALITY ASSOCIATED WITH USE OF ANTIPSYCHOTICS IN DEMENTIA: REVIEWING THE EVIDENCE

MORTALITY ASSOCIATED WITH USE OF ANTIPSYCHOTICS IN DEMENTIA: REVIEWING THE EVIDENCE MORTALITY ASSOCIATED WITH USE OF ANTIPSYCHOTICS IN DEMENTIA: REVIEWING THE EVIDENCE KRISTA L. LANCTÔT, PHD PROFESSOR OF PSYCHIATRY AND PHARMACOLOGY, UNIVERSITY OF TORONTO; SENIOR SCIENTIST, HURVITZ BRAIN

More information

Critical Care Pharmacological Management of Delirium

Critical Care Pharmacological Management of Delirium Critical Care Pharmacological Management of Delirium Policy Title: in the Critical Care Unit Executive Summary: This policy provides guidance Pharmacological Management of delirium in the Critical Care

More information

Challenging ASD Cases November 11, Melanie Penner, MD, MSc, Mohammad Zubairi, MD, MEd,

Challenging ASD Cases November 11, Melanie Penner, MD, MSc, Mohammad Zubairi, MD, MEd, Challenging ASD Cases November 11, 2017 Melanie Penner, MD, MSc, FRCPC @drmelpenner Mohammad Zubairi, MD, MEd, FRCPC @md_mszubairi Learning Objectives By the end of this workshop, participants will: 1)

More information

9/11/2012. Clare I. Hays, MD, CMD

9/11/2012. Clare I. Hays, MD, CMD Clare I. Hays, MD, CMD Review regulatory background for current CMS emphasis on antipsychotics Understand the risks and (limited) benefits of antipsychotic medications Review non-pharmacologic management

More information

Dementia: Rethinking our approach to behaviour

Dementia: Rethinking our approach to behaviour Dementia: Rethinking our approach to behaviour Dr Kathryn Lord Research Fellow 1 A bit about me: The 3 P s! Psychology Psychiatry Person centredcare 2 Challenging behaviours in Challenging behaviours dementia

More information

Amanda Adams-Fryatt RN MN Nurse Practitioner WRHA

Amanda Adams-Fryatt RN MN Nurse Practitioner WRHA Amanda Adams-Fryatt RN MN Nurse Practitioner WRHA Discuss the prevalence of BPSD Discuss the etiology of Disruptive Vocalizing Discuss memory and communication Discuss the Needs-Based Models Discuss the

More information

Atypical Antipsychotics and the Risk of Diabetes in an Elderly Population in Long-Term Care: A Retrospective Nursing Home Chart Review Study

Atypical Antipsychotics and the Risk of Diabetes in an Elderly Population in Long-Term Care: A Retrospective Nursing Home Chart Review Study Atypical Antipsychotics and the Risk of Diabetes in an Elderly Population in Long-Term Care: A Retrospective Nursing Home Chart Review Study Stewart G. Albert, MD, George T. Grossberg, MD, Papan J. Thaipisuttikul,

More information

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD

Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Presented by Rengena Chan-Ting, DO, CMD, FACOI Jenna D. Toniatti, PharmD Define BPSD and review the spectrum of associated symptoms Review pharmacologic and non-pharmacologic treatments for BPSD Evaluate

More information

Learning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016

Learning Objectives. Delirium. Delirium. Delirium. Terminal Restlessness 3/28/2016 Terminal Restlessness Dr. Christopher Churchill St. Cloud VA Health Care System EC&R Service Line Director & Medical Director Hospice & Palliative Care March 31, 2016 Learning Objectives Different Terminology

More information

Psychotropic Medication. Including Role of Gradual Dose Reductions

Psychotropic Medication. Including Role of Gradual Dose Reductions Psychotropic Medication Including Role of Gradual Dose Reductions What are they? The phrase psychotropic drugs is a technical term for psychiatric medicines that alter chemical levels in the brain which

More information

Improving Meaningful Engagement (ME) in LTC Residents with Dementia: Applying the MemPics Program

Improving Meaningful Engagement (ME) in LTC Residents with Dementia: Applying the MemPics Program Improving Meaningful Engagement (ME) in LTC Residents with Dementia: Applying the MemPics Program Presented by Dr. William Mansbach Founder & CEO, Mansbach Health Tools, LLC Home of the BCAT at www.thebcat.com

More information

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people

NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE SCOPE. Dementia: the management of dementia, including the use of antipsychotic medication in older people NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE 1 Guideline title SCOPE Dementia: the management of dementia, including the use of antipsychotic medication in older people 1.1 Short title Dementia 2 Background

More information

DELIRIUM IN ICU: Prevention and Management. Milind Baldi

DELIRIUM IN ICU: Prevention and Management. Milind Baldi DELIRIUM IN ICU: Prevention and Management Milind Baldi Contents Introduction Risk factors Assessment Prevention Management Introduction Delirium is a syndrome characterized by acute cerebral dysfunction

More information

Medications for treating people with dementia: summary of evidence on cost-effectiveness

Medications for treating people with dementia: summary of evidence on cost-effectiveness Medications for treating people with dementia: summary of evidence on cost-effectiveness Martin Knapp, A-La Park and Alistair Burns PSSRU, London School of Economics and Political Science v4 23 July 2017

More information

Why is training not enough to make a difference in dementia care? Acknowledgements. Staff attitudes need to encourage:

Why is training not enough to make a difference in dementia care? Acknowledgements. Staff attitudes need to encourage: Why is training not enough to make a difference in dementia care? Bob Woods Professor of Clinical Psychology of Older People University of Wales Bangor b.woods@bangor.ac.uk Acknowledgements Tracey Lintern

More information

DRAFT. Consultees are asked to consider and comment on the CEPP National Audit: Antipsychotics in Dementia document.

DRAFT. Consultees are asked to consider and comment on the CEPP National Audit: Antipsychotics in Dementia document. Enclosure No: Agenda item No: Author: Contact: xx/xxxxx/xxxx0918 xx CEPP National Audit: Antipsychotics in Dementia All Wales Therapeutics and Toxicology Centre Tel: 02920 71 6900 awttc@wales.nhs.uk 1.0

More information

Workshop cases answers

Workshop cases answers Workshop cases answers BPSD Workshop: case histories Case 1: Mrs DM Scenario This is an 83 year old lady diagnosed with multi infarct dementia in 2008. Lives with husband and the couple are supported by

More information

MENTAL HEALTH DISEASE CLASSIFICATIONS

MENTAL HEALTH DISEASE CLASSIFICATIONS MENTAL HEALTH DISEASE CLASSIFICATIONS DIAGNOSIS OF MENTAL DISORDERS DSM-IV-TR Published by APA ( 2000 ) Multiaxial system 5 categories called axes Facilitate holistic assessment for care Is a great resource

More information

According to the U.S. Department of Health and Human

According to the U.S. Department of Health and Human Web audio at CurrentPsychiatry.com Dr. Kales: Risks and benefits of antipsychotics and other psychotropics for behavioral and psychological symptoms of dementia THIRD OF 3 PARTS Prescribing antipsychotics

More information

CEPP National Audit Antipsychotics in Dementia

CEPP National Audit Antipsychotics in Dementia CEPP National Audit Antipsychotics in Dementia December 2018 This document has been prepared by a multiprofessional collaborative group, with support from the All Wales Prescribing Advisory Group (AWPAG)

More information

Basic Standards for Residency/Fellowship Training in Geriatric Psychiatry

Basic Standards for Residency/Fellowship Training in Geriatric Psychiatry Basic Standards for Residency/Fellowship Training in Geriatric Psychiatry American Osteopathic Association and American College of Osteopathic Neurologists and Psychiatrists Approved 2/2005 Revised 2/2008,

More information

Dementia Support Across the Care Continuum

Dementia Support Across the Care Continuum Dementia Support Across the Care Continuum Michelle Niedens, L.S.C.S.W. Director of Education, Programs and Public Policy Alzheimer's Association - Heart of America Chapter July 16, 2015 DEMENTIA SUPPORT

More information

Test your Knowledge: Recognizing Delirium

Test your Knowledge: Recognizing Delirium The Ottawa Hospital Name: Unit: Profession: RN RPN PT OT SW Other Note: Each question has only one correct answer. 1. If a patient is identified as being at high risk for developing delirium, his/her mental

More information

Neuropsychiatric Syndromes

Neuropsychiatric Syndromes Neuropsychiatric Syndromes Susan Czapiewski,MD VAHCS December 10, 2015 Dr. Czapiewski has indicated no potential conflict of interest to this presentation. She does intend to discuss the off-label use

More information

CHCS. Multimorbidity Pattern Analyses and Clinical Opportunities: Dementia. Center for Health Care Strategies, Inc. FACES OF MEDICAID DATA SERIES

CHCS. Multimorbidity Pattern Analyses and Clinical Opportunities: Dementia. Center for Health Care Strategies, Inc. FACES OF MEDICAID DATA SERIES CHCS Center for Health Care Strategies, Inc. FACES OF MEDICAID DATA SERIES Multimorbidity Pattern Analyses and Clinical Opportunities: Dementia December 2010 Cynthia Boyd, MD, MPH* Bruce Leff, MD* Carlos

More information

12/17/2012. Unnecessary Drugs

12/17/2012. Unnecessary Drugs Nursing Home Social Work Webinar Series December 19, 2012 Dr. Robin P. Bonifas, PhD, MSW Arizona State University School of Social Work Importance of familiarity with psychotropic medication regulations.

More information

Opinion statement. Introduction. Cognitive Disorders (M Geschwind, Section Editor)

Opinion statement. Introduction. Cognitive Disorders (M Geschwind, Section Editor) Current Treatment Options in Neurology DOI 10.1007/s11940-012-0166-9 Cognitive Disorders (M Geschwind, Section Editor) Treatment of Behavioral and Psychological Symptoms of Alzheimer s Disease Anne Corbett,

More information

Delirium. Approach. Symptom Update Masterclass:

Delirium. Approach. Symptom Update Masterclass: Symptom Update Masterclass: Delirium Jason Boland Senior Clinical Lecturer and Honorary Consultant in Palliative Medicine Wolfson Centre for Palliative Care Research Hull York Medical School University

More information

Pharmacists as a vital part of the mental health of the nation

Pharmacists as a vital part of the mental health of the nation Pharmacists as a vital part of the mental health of the nation P H I L I P P I N E S P H A R M A C Y A S S O C I A T I O N C O N V E N T I O N A P R I L 2 5, 2 0 1 5 B A C O L O D T R U D I H I L T O N

More information

Delirium in the Elderly

Delirium in the Elderly Delirium in the Elderly ELITE 2017 Liza Genao, MD Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity Very much under-recognized

More information

Management of Behavioral Symptoms in Dementia. Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal

Management of Behavioral Symptoms in Dementia. Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal Management of Behavioral Symptoms in Dementia Brenda Jordan, MS, ARNP, BC- PCM Dartmouth-Hitchcock Kendal Behavioral Symptoms Common & troubling At least one will occur in 61-92% of those with any dementia

More information

Delirium in the Elderly

Delirium in the Elderly Delirium in the Elderly ELITE 2015 Mamata Yanamadala M.B.B.S, MS Division of Geriatrics Why should we care about delirium? It is: common associated with high mortality associated with increased morbidity

More information

Treatment of behavioral and psychological symptoms of dementia: a systematic review

Treatment of behavioral and psychological symptoms of dementia: a systematic review Psychiatr. Pol. 2016; 50(4): 679 715 PL ISSN 0033-2674 (PRINT), ISSN 2391-5854 (ONLINE) www.psychiatriapolska.pl DOI: http://dx.doi.org/10.12740/pp/64477 Treatment of behavioral and psychological symptoms

More information

Psychotropic Medication Use in Canadian Long-Term Care Patients Referred for Psychogeriatric Consultation

Psychotropic Medication Use in Canadian Long-Term Care Patients Referred for Psychogeriatric Consultation Original Research Psychotropic Medication Use in Canadian Long-Term Care Patients Referred for Psychogeriatric Consultation Corinne E. Fischer, MD 1,2,3, Carole Cohen, MD 3,4, Lauren Forrest, BSc 3, Tom

More information

Delirium, Depression and Dementia

Delirium, Depression and Dementia Delirium, Depression and Dementia Martha Watson, MS, APRN, GCNS Some material included in this presentation is adapted from: NICHE (2009). Geriatric Resource Nurse Core Curriculum [Power Point presentation].

More information

Depression in the Eldery Handout Package

Depression in the Eldery Handout Package Depression in the Eldery Handout Package Depression in the Elderly 1 Learning Objectives Upon completion of this module, you should be able to: 1. State the prevalence and describe the consequences of

More information

Management of Behavioral and Psychological Symptoms in People with Dementia Living in Care Homes: A UK Perspective

Management of Behavioral and Psychological Symptoms in People with Dementia Living in Care Homes: A UK Perspective Management of Behavioral and Psychological Symptoms in People with Dementia Living in Care Homes: A UK Perspective Clive Ballard Professor of Age Related Diseases, King s College London And Director of

More information

APNA 25th Annual Conference October 21, Session 3014

APNA 25th Annual Conference October 21, Session 3014 Clinical Decision Making to Manage Disruptive Behavior in Older Adults: What Psychiatric Nurses Say They Do vs. What They Document Dr. Pam Lindsey Assistant Professor Millikin University School of Nursing

More information

Marita P. McCabe a *,MichaelBird b, Tanya E. Davison c, David Mellor a, Sarah MacPherson d, David Hallford a and Melissa Seedy a

Marita P. McCabe a *,MichaelBird b, Tanya E. Davison c, David Mellor a, Sarah MacPherson d, David Hallford a and Melissa Seedy a Aging & Mental Health, 2015 Vol. 19, No. 9, 799 807, http://dx.doi.org/10.1080/13607863.2014.967659 An RCT to evaluate the utility of a clinical protocol for staff in the management of behavioral and psychological

More information

JBI Database of Systematic Reviews & Implementation Reports 2014;12(9)

JBI Database of Systematic Reviews & Implementation Reports 2014;12(9) Assessment and non-pharmacological management among adults with a dementia diagnosis in a residential care setting: a best practice implementation project Antonia Hynes RN Dip. Management 1 Sue Beirne

More information

Across the Spectrum of Dementia. Keys to Understanding Behaviours & Anticipating Needs

Across the Spectrum of Dementia. Keys to Understanding Behaviours & Anticipating Needs Across the Spectrum of Dementia Keys to Understanding Behaviours & Anticipating Needs Outline Review current predictions for dementia prevalence, & the implications for future needs Discuss retrogenesis

More information

Presenter: Dr M. Elizabeth Collerson Health Law Research Program Queensland University of Technology

Presenter: Dr M. Elizabeth Collerson Health Law Research Program Queensland University of Technology Presenter: Dr M. Elizabeth Collerson Health Law Research Program Queensland University of Technology Chief Investigators Queensland University of Technology Associate Professor Ben White Professor Lindy

More information

An#psycho#c Medica#on in People with Demen#a

An#psycho#c Medica#on in People with Demen#a An#psycho#c Medica#on in People with Demen#a GERARD BYRNE BSc (Med), MBBS (Hons), PhD, FRANZCP, MFPOA School of Medicine, University of Queensland Mental Health Service, Royal Brisbane & Women s Hospital

More information

Supporting people with dementia to live well in London care homes

Supporting people with dementia to live well in London care homes Supporting people with dementia to live well in London care homes London Dementia Clinical Network Date Dr Daniel Harwood; Clinical Director and Consultant Psychiatrist SLAM (Lewisham Care Home Intervention

More information

Older People Mental Health - new directorate/new plans. Dr Adrian Treloar Clinical director

Older People Mental Health - new directorate/new plans. Dr Adrian Treloar Clinical director Older People Mental Health - new directorate/new plans Dr Adrian Treloar Clinical director Dementia 700,000 people in the UK currently have dementia; this number is set to double by 2038 1/3 of people

More information

GEC Delirium Resource Review Form

GEC Delirium Resource Review Form Resource Name: GEC Delirium Resource Review Form Delirium or Dementia: Delirium Morbidity and Mortality Case http://www.webmm.ahrq.gov/case.aspx?caseid=200 Reviewer Name: Eleanor S. McConnell, PhD, RN,

More information

Research Journal of Pharmaceutical, Biological and Chemical Sciences

Research Journal of Pharmaceutical, Biological and Chemical Sciences Research Journal of Pharmaceutical, Biological and Chemical Sciences Prescribing Pattern of Antipsychotics In A Tertiary Care Hospital, Salem: A Retrospective Study. B Arul 1 *, E Manivannan 2, R Kothai

More information

TRANSPARENCY COMMITTEE Opinion 19 February 2014

TRANSPARENCY COMMITTEE Opinion 19 February 2014 The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 19 February 2014 RISPERDAL 1 mg, scored film-coated tablet B/60 (CIP: 34009 338 948 7 0) RISPERDAL 2 mg, scored film-coated

More information

Delirium. Dr. John Puxty

Delirium. Dr. John Puxty Delirium Dr. John Puxty Learning Objectives By the end of the workshop participants will be able to: Appreciate the main diagnostic criteria for delirium. Describe common risk factors, causes and main

More information